NeuroMetrix announced that Quell will be one of 30 companies to present their latest innovations at CES Unveiled New York on November 10.
CES Unveiled is produced by the Consumer Electronics Association to provide a sneak peek at the year’s most innovative products two months before CES 2016. The event will highlight innovation in health and fitness, automotive technology, sports, smart home, virtual reality and more.
"CES is an important venue for companies launching and developing consumer health technology brands," said Frank McGillin, Senior VP and General Manager of NeuroMetrix Consumer.
"We are proud to have been selected as one of four finalists for the 2015 Best of CES Award in the health and fitness category. At CES Unveiled, we will share how Quell is creating an entirely new category of wearables."
Quell is an easy-to-use, over-the-counter device for relief of chronic pain. This wearable device utilizes NeuroMetrix’s wearable intensive nerve stimulation (WINS) technology to provide pain relief.
In a recent clinical study, Quell was shown to improve chronic pain and overall health in 81% of participants.
NeuroMetrix is an innovative health-care company that develops wearable medical technology and point-of-care tests that help patients and physicians better manage chronic pain, nerve diseases, and sleep disorders.